Gyre Therapeutics (GYRE) Sales of Property, Plant and Equipment (2013 - 2026)

Gyre Therapeutics (GYRE) Sales of Property, Plant and Equipment (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Gyre Therapeutics 554.75 Mn 540.62 Mn 8.38 Mn 6,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 6,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 11,000.00
Dec 31, 2025 11,000.00
Jun 30, 2025 18,000.00
Jun 30, 2025 18,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 138,000.00
Dec 31, 2024 138,000.00
Sep 30, 2024 -5,000.00
Sep 30, 2024 -5,000.00
Jun 30, 2024 218,000.00
Jun 30, 2024 218,000.00
Mar 31, 2024 50,000.00
Mar 31, 2024 50,000.00
Dec 31, 2023 167,000.00
Dec 31, 2023 167,000.00
Sep 30, 2023 363,000.00
Sep 30, 2023 363,000.00